<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>tumour microenvironment &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/tumour-microenvironment/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Tue, 06 Oct 2026 14:29:56 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.1.2</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>tumour microenvironment &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>Nanovaccine Built From Metal–Organic Frameworks Drives Tumours Into Full Retreat</title>
		<link>https://bioengineer.org/nanovaccine-built-from-metal-organic-frameworks-drives-tumours-into-full-retreat/</link>
		
		<dc:creator><![CDATA[]]></dc:creator>
		<pubDate>Tue, 06 Oct 2026 14:29:56 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[antigen presentation]]></category>
		<category><![CDATA[cancer vaccine]]></category>
		<category><![CDATA[immune checkpoint blockade]]></category>
		<category><![CDATA[immunotherapy]]></category>
		<category><![CDATA[macrophages]]></category>
		<category><![CDATA[Metal-Organic Frameworks]]></category>
		<category><![CDATA[nanoparticles]]></category>
		<category><![CDATA[neoantigens]]></category>
		<category><![CDATA[Radiotherapy]]></category>
		<category><![CDATA[STING agonist]]></category>
		<category><![CDATA[T Cells]]></category>
		<category><![CDATA[tumour microenvironment]]></category>
		<guid isPermaLink="false">https://bioengineer.org/?p=404342</guid>

					<description><![CDATA[A metal–organic framework nanovaccine co-delivering tumour antigens and STING agonists induced systemic tumour regression, immune memory and synergy with radiotherapy and checkpoint blockade across five cancer types in mice.]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">404342</post-id>	</item>
		<item>
		<title>Antibody–Drug Conjugates Emerge as Immune Modulators, Not Just Targeted Chemotherapy</title>
		<link>https://bioengineer.org/antibody-drug-conjugates-emerge-as-immune-modulators-not-just-targeted-chemotherapy/</link>
		
		<dc:creator><![CDATA[]]></dc:creator>
		<pubDate>Tue, 06 Oct 2026 14:08:56 +0000</pubDate>
				<category><![CDATA[Cancer]]></category>
		<category><![CDATA[antibody-dependent cellular cytotoxicity]]></category>
		<category><![CDATA[antibody-drug conjugates]]></category>
		<category><![CDATA[bispecific antibodies]]></category>
		<category><![CDATA[Breast Cancer]]></category>
		<category><![CDATA[cGAS-STING pathway]]></category>
		<category><![CDATA[dendritic cells]]></category>
		<category><![CDATA[enfortumab vedotin]]></category>
		<category><![CDATA[Immune checkpoint inhibitors]]></category>
		<category><![CDATA[immunogenic cell death]]></category>
		<category><![CDATA[trastuzumab deruxtecan]]></category>
		<category><![CDATA[tumour microenvironment]]></category>
		<category><![CDATA[urothelial cancer]]></category>
		<guid isPermaLink="false">https://bioengineer.org/?p=404312</guid>

					<description><![CDATA[A new review argues that antibody–drug conjugates act as immune modulators through immunogenic cell death, Fc-mediated effector functions and tumour microenvironment reprogramming, reshaping how they are combined with immunotherapy.]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">404312</post-id>	</item>
	</channel>
</rss>
